GlassScriptPhysician profile
Alibel Bello
NPI 1841723640
$4,209.72
in general payments reported to CMS, 2019-2025
20 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $1,891 · 2023: $1,344 · 2024: $377 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104 · Travel and Lodging: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.43 |
| Travel and Lodging | $793.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,671.57 | 2022-2023 | Illumisite |
| Glaxosmithkline, LLC. | $580.33 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $455.00 | 2021-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $305.22 | 2021-2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $226.86 | 2022-2025 | |
| Genzyme Corporation | $221.94 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $123.39 | 2023-2024 | Uptravi, Opsumit |
| Insmed, INC. | $101.59 | 2021 | |
| Pulmonx Corporation | $83.61 | 2021-2022 | |
| Mylan Specialty L.P. | $74.13 | 2022 | |
| Intuitive Surgical, INC. | $64.50 | 2024 | |
| Olympus America INC. | $58.71 | 2025 | |
| Gilead Sciences, INC. | $57.42 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $47.79 | 2021-2022 | |
| United Therapeutics Corporation | $41.78 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $25.88 | 2022 | |
| Pfizer INC. | $18.70 | 2021 | |
| Ambu INC. | $18.31 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.99 | 2023 | |
| Erbe USA INC | $15.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alibel Bello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.